SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
Clinical trials for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug trial halted early: what we know
Disease control TerminatedThis early-stage study tested a new drug called INCA00186, alone or with other immunotherapy drugs, in people with advanced solid tumors like head and neck or gastrointestinal cancers. The goal was to check safety and find the right dose. The study was stopped early, so results a…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 26, 2026 12:04 UTC
-
Pfizer cancer drug trial halted early after only 8 patients
Disease control TerminatedThis early-stage study tested a new drug called PF-08046037, given alone or with another drug (sasanlimab), in people with advanced lung, head and neck, melanoma, or pancreatic cancers. The goal was to check safety and how the body processes the drug. Only 8 people took part befo…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 22, 2026 13:52 UTC